'Super Office' To The Rescue: FDA's Device Center Is About To Undergo A 'Total Product Life Cycle' Makeover

CDRH Director Jeff Shuren told industry that the device center is moving quickly to establish a "super office" to tackle the full spectrum of pre- and post-market issues to reduce inefficiencies to replace the more siloed approach. Chief Scientist Bill Maisel has already been named a director.

Jeff Shuren
CDRH Director Jeff Shuren took industry questions at AdvaMed's Medtech Conference 2017 FDA town hall • Source: Ferdous Al-Faruque

More from Regulation

More from Policy & Regulation